Cancer, Lung Clinical Trial
Official title:
A Brief Messaging Lifestyle Modification Program for Patients With Non-small Cell Lung Cancer - A Pilot Study
Lung cancer is one of the most common cancer diseases, globally and locally. Several health
benefits of increased physical activity (PA) have been reported for people with cancer. PA
plays a critical role across the cancer trajectory, from prevention through to post-diagnosis
and has been proposed as an alternative for improving physical and psychosocial health
outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality.
Although there are a variety of exercise intervention programs for cancer patients, those
programs were quite intensive, requiring individuals to commit extra time and effort. Feeling
of overwhelmed appointments, lack of time, other barriers, including high cost and limited
access to facilities are the most frequently reported barriers that prevent people from
starting and maintaining exercise. Hence, the investigators propose to use a brief messaging
lifestyle modification intervention program to incorporating simple and easy-to-do
patient-centred home-based lifestyle-integrated exercise into daily activities of patients
with lung cancer. The aims are to increase patients' physical activity and improve their
fatigue, emotion and quality of life, compared to the control group.
Lung cancer is one of the most common cancer, globally and locally. Patients with lung cancer
are in a uniquely challenging situation in their disease, comorbidities, and treatment that
may lead to worsened symptoms and many negative health consequences, including fatigue,
irritability, and impaired daytime functioning.
Physical activity (PA) is defined as 'any bodily movement produced by skeletal muscle that
results in energy expenditure'. Several health benefits of increased PA have been reported
for people with cancer. PA plays a critical role across the cancer trajectory, from
prevention through to post-diagnosis and has been proposed as an alternative for improving
physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific
and all-cause mortality. Although there are a variety of exercise intervention programs for
cancer patients, those programs were quite intensive, requiring individuals to commit extra
time and effort. Most clinicians underutilise exercise therapy, regardless of its low-cost
way to improve symptoms and potential health outcomes. Feeling of overwhelmed appointments,
lack of time, other barriers, including high cost and limited access to facilities are the
most frequently reported barriers that prevent people from starting and maintaining exercise.
Low motivation, fear to exercise, lack of knowledge about benefits are the most common
barriers of engaging in physical activity for cancer patients.
Hence, the current proposal is to use a brief messaging lifestyle modification intervention
program to incorporating simple and easy-to-do patient-centred home-based
lifestyle-integrated exercise (light to moderate physical activity) into daily activities of
patients with lung cancer.
The investigators hypothesised that patients in the experimental group would display
significantly higher increases in physical activity and improvements in fatigue, emotion and
quality of life, compared to the control group.
The objectives are to examine the short-term clinical effects on impacts on fatigue, emotion
and quality of life in patients with lung cancer, and to evaluate the feasibility of a brief
lifestyle-integrated exercise program to increase physical activity by a pilot study with
objective fitness and subjective questionnaire assessment, and focus group interviews.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06152419 -
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
|
N/A | |
Completed |
NCT05732350 -
Exploratory Drug Interaction Study Between SMIs and DOACs
|
||
Active, not recruiting |
NCT04300244 -
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
|
Phase 2 | |
Recruiting |
NCT05311709 -
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
|
Phase 2 | |
Active, not recruiting |
NCT04396457 -
Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901
|
Phase 2 | |
Recruiting |
NCT06391749 -
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
|
||
Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
Recruiting |
NCT03301493 -
Genomic Testing and Resulting Medical Decisions
|
||
Completed |
NCT04788147 -
Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)
|
N/A | |
Not yet recruiting |
NCT06035731 -
Evaluation of the Medical Service by Socio-aesthetics in Oncology
|
N/A | |
Recruiting |
NCT03274349 -
Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial Carcinoma
|
N/A | |
Recruiting |
NCT05830097 -
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02991677 -
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
|
N/A | |
Completed |
NCT04971304 -
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
|
||
Recruiting |
NCT04859400 -
Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients
|
N/A | |
Recruiting |
NCT05948865 -
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
|
Phase 1 | |
Recruiting |
NCT04270890 -
Investigation of an Abdominal Compression Device
|
N/A | |
Not yet recruiting |
NCT05154474 -
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
|
||
Not yet recruiting |
NCT05857995 -
Precision Lung Cancer Survivorship Care Intervention
|
N/A | |
Not yet recruiting |
NCT03622528 -
Quantitative Lung Cancer Screening
|